Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hims & Hers Health Inc (NY: HIMS ) 20.36 +1.53 (+8.13%) Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 12,245,000 Open 19.00 Bid (Size) 20.40 (4) Ask (Size) 20.48 (5) Prev. Close 18.83 Today's Range 18.70 - 20.59 52wk Range 6.230 - 25.74 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why October 30, 2024 Hims & Hers Health shares are falling Thursday following an FDA update listing Novo Nordisk diabetes drug Ozempic and weight-loss drug Wegovy as available, signaling possible supply stability. Here's... Via Benzinga Exposures Product Safety Smart Money Is Betting Big In HIMS Options October 30, 2024 Via Benzinga Performance YTD +111.20% +111.20% 1 Month +15.29% +15.29% 3 Month +14.13% +14.13% 6 Month +74.76% +74.76% 1 Year +224.20% +224.20% More News Read More 12 Health Care Stocks Moving In Wednesday's Intraday Session October 30, 2024 Via Benzinga Could This Magnificent Pharma Stock 10x in the Next 5 Years? October 30, 2024 Via The Motley Fool How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals October 29, 2024 From Hims & Hers Via Business Wire A Look Into Hims & Hers Health Inc's Price Over Earnings October 22, 2024 Via Benzinga How Is The Market Feeling About Hims & Hers Health? October 22, 2024 Via Benzinga This Is What Whales Are Betting On Hims & Hers Health October 21, 2024 Via Benzinga Top 3 Stocks Institutions Are Buying Right Now October 28, 2024 Via MarketBeat Hims & Hers Stock Dropped: Here's What You Need to Know October 24, 2024 Via The Motley Fool Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity' October 23, 2024 Via Benzinga Exposures Product Safety Decoding 6 Analyst Evaluations For Hims & Hers Health October 21, 2024 Via Benzinga Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers October 21, 2024 From Hims & Hers Via Business Wire In-Depth Examination Of 6 Analyst Recommendations For Hims & Hers Health October 21, 2024 Via Benzinga What Is Going On With Hims & Hers Stock? October 11, 2024 Via The Motley Fool Why Hims & Hers' Incredible Growth Will Continue October 18, 2024 Via The Motley Fool Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk. October 16, 2024 Via Investor's Business Daily Exposures Product Safety Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024 October 14, 2024 From Hims & Hers Via Business Wire Hims & Hers Health Stock Is Popping Monday: What's Behind The Move? October 14, 2024 Via Benzinga Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug October 14, 2024 Via Investor's Business Daily Topics Lawsuit Exposures Financial Legal Product Safety Where Does Hims & Hers Stock Go From Here? October 12, 2024 Via The Motley Fool Exposures Product Safety 2 Incredibly Cheap Growth Stocks to Buy Right Now October 12, 2024 Via The Motley Fool 2 No-Brainer Growth Stocks to Buy With $500 Right Now October 12, 2024 Via The Motley Fool Top 3 Stocks with Explosive Call Option Activity: What to Watch October 10, 2024 Via MarketBeat FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List October 08, 2024 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
